resniben

Frequently asked questions

What does Resniben treat?

Resniben (Cabozantinib) may be used to treat renal cell carcinoma, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.

How is Resniben rated?

pharmaranks gives Resniben a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.

Is there a coupon or discount for Resniben?

pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Resniben. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.

Who makes Resniben?

Resniben is marketed by Azurity. You can see Azurity's full profile, rating, and other products on pharmaranks.

Is Resniben a brand-name or generic drug?

Resniben is a brand-name product with the active ingredient Cabozantinib.

Is Resniben available over the counter?

No. Resniben is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.

What forms does Resniben come in?

Resniben is currently marketed as tablet, per the FDA's National Drug Code Directory.

Is Resniben FDA-registered?

Resniben is on record with the U.S. FDA under application number NDA220258. You can verify this on its official FDA label.

Has Resniben been recalled by the FDA?

Resniben has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.

Is Resniben safe?

There's no single safe-or-not verdict. pharmaranks gives Resniben a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.